Mallinckrodt Announces Real World Data on Hepatorenal Syndrome (HRS) and Acute Kidney Injury (AKI) in Patients with Liver Disease at The Liver Meeting Digital Experience
- Monday, November 16, 2020, 7:01
- Finance
- Add a comment
DUBLIN, Nov. 16, 2020 /PRNewswire/ — Mallinckrodt plc, a global biopharmaceutical company, today announced findings from a large U.S. database review of patient profiles and outcomes of patients hospitalized with hepatorenal syndrome (HRS) and acute kidney injury (AKI). The descriptive…
About the Author
adminasapcorp has written 41611 stories on this site.